drugset / Trial / NCT06785662
Budesonide Irrigation in Allergic Rhinitis
RandomizedParallel-groupSingle-blindTreatment
Summary
Topical nasal steroids are significant therapeutic options for allergic rhinitis (AR). The distribution of intranasal steroid spray (INS) administration is less than that of irrigation. However, the available data on steroid nasal irrigation is limited. This article aims to evaluate the efficacy and adverse effects (AEs) of steroid irrigation in AR patients.
Timeline
- Start
- 2025-02-12
- Primary completion
- 2026-01-01
- Completion
- 2026-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 64 ug | Intranasal |
| Subject | Budesonide | Small molecule | 1 mg | Intranasal |